Physiomics Plc (LON:PYC – Get Free Report)’s share price shot up 7.6% during trading on Thursday . The company traded as high as GBX 0.54 and last traded at GBX 0.54. Approximately 4,022,303 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 7,405,446 shares. The stock had previously closed at GBX 0.50.
Physiomics Stock Performance
The firm’s 50 day simple moving average is GBX 0.55 and its 200-day simple moving average is GBX 0.44. The company has a market capitalization of £2.44 million, a price-to-earnings ratio of -3.59 and a beta of 0.95.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
Featured Articles
- Five stocks we like better than Physiomics
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
